Literature DB >> 32374675

Thrombospondin-1 in maladaptive aging responses: a concept whose time has come.

Jeffrey S Isenberg1, David D Roberts2.   

Abstract

Numerous age-dependent alterations at the molecular, cellular, tissue and organ systems levels underlie the pathophysiology of aging. Herein, the focus is upon the secreted protein thrombospondin-1 (TSP1) as a promoter of aging and age-related diseases. TSP1 has several physiological functions in youth, including promoting neural synapse formation, mediating responses to ischemic and genotoxic stress, minimizing hemorrhage, limiting angiogenesis, and supporting wound healing. These acute functions of TSP1 generally require only transient expression of the protein. However, accumulating basic and clinical data reinforce the view that chronic diseases of aging are associated with accumulation of TSP1 in the extracellular matrix, which is a significant maladaptive contributor to the aging process. Identification of the relevant cell types that chronically produce and respond to TSP1 and the molecular mechanisms that mediate the resulting maladaptive responses could direct the development of therapeutic agents to delay or revert age-associated maladies.

Entities:  

Keywords:  CD47; aging; cardiovascular and metabolic disease; self-renewal; senescence; thrombospondin-1

Mesh:

Substances:

Year:  2020        PMID: 32374675      PMCID: PMC7468894          DOI: 10.1152/ajpcell.00089.2020

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  230 in total

1.  Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage.

Authors:  D Pfander; T Cramer; D Deuerling; G Weseloh; B Swoboda
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  The association between age and nephrosclerosis on renal biopsy among healthy adults.

Authors:  Andrew D Rule; Hatem Amer; Lynn D Cornell; Sandra J Taler; Fernando G Cosio; Walter K Kremers; Stephen C Textor; Mark D Stegall
Journal:  Ann Intern Med       Date:  2010-05-04       Impact factor: 25.391

3.  Longitudinal effects of aging on lung function at rest and exercise in healthy active fit elderly adults.

Authors:  S R McClaran; M A Babcock; D F Pegelow; W G Reddan; J A Dempsey
Journal:  J Appl Physiol (1985)       Date:  1995-05

4.  Capillary growth, ultrastructure remodelling and exercise training in skeletal muscle of essential hypertensive patients.

Authors:  L Gliemann; R Buess; M Nyberg; H Hoppeler; A Odriozola; P Thaning; Y Hellsten; O Baum; S P Mortensen
Journal:  Acta Physiol (Oxf)       Date:  2015-04-24       Impact factor: 6.311

5.  Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures.

Authors:  Ramez I Haddadin; Dong-Jin Oh; Min Hyung Kang; Guadalupe Villarreal; Ja-Heon Kang; Rui Jin; Haiyan Gong; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-28       Impact factor: 4.799

6.  Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium.

Authors:  I Gotis-Graham; P J Hogg; H P McNeil
Journal:  Arthritis Rheum       Date:  1997-10

7.  CD47 regulates bone mass and tumor metastasis to bone.

Authors:  Ozge Uluçkan; Stephanie N Becker; Hongju Deng; Wei Zou; Julie L Prior; David Piwnica-Worms; William A Frazier; Katherine N Weilbaecher
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

8.  Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.

Authors:  Jeff S Isenberg; Justin B Maxhimer; Perlita Powers; Maria Tsokos; William A Frazier; David D Roberts
Journal:  Surgery       Date:  2008-09-02       Impact factor: 3.982

9.  Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1.

Authors:  T F Lane; M L Iruela-Arispe; E H Sage
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

10.  Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency.

Authors:  Victor R Gordeuk; Vandana Sachdev; James G Taylor; Mark T Gladwin; Gregory Kato; Oswaldo L Castro
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

View more
  3 in total

Review 1.  The ocular surface immune system through the eyes of aging.

Authors:  Jeremias G Galletti; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2021-02-20       Impact factor: 5.033

2.  Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Yi-Chen Li; John Y Chiang; Chi-Hsiang Chu; Pei-Lin Shao; Fan-Yen Lee; Mel S Lee; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2020-07-29       Impact factor: 6.832

3.  PDIA3/ERp57 promotes a matrix-rich secretome that stimulates fibroblast adhesion through CCN2.

Authors:  Andrew L Hellewell; Kate J Heesom; Mark A Jepson; Josephine C Adams
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-23       Impact factor: 5.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.